Antibody Therapy Achieves Slight Reduction in Recurrence for Women With HER2-positive DCIS, Says Study - MY HEALTH TODAY

Breaking

Home Top Ad

Responsive Ads Here

Post Top Ad

Responsive Ads Here

Sunday, May 31, 2020

Antibody Therapy Achieves Slight Reduction in Recurrence for Women With HER2-positive DCIS, Says Study

Trastuzumab was found to achieve a slight reduction in recurrence for women with HER2-positive ductal carcinoma in situ, stated clinical trial results.


from Medindia Health News https://ift.tt/2yM40j0
via

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages